Posts with tag Biobanking

Last month, the Belgian Parliament voted in favour of a set of measures that are notably meant to clarify the regulatory landscape of the operators active in the manufacturing of Advanced Therapy Medicinal Products (ATMPs), a category of medicinal products that includes gene therapies, cell therapies and tissue-engineered products. The use of human tissues and cells in medicinal products is widely harmonized in the EU, given that it is regulated through (i) a Regulation (Regulation (EC)...